Background
==========

Leukoaraiosis is characterized by white matter lesions (WMLs) of presumed vascular origin on T~2~-weighted magnetic resonance images (MRIs) and fluid attenuated inversion recovery (FLAIR) MRIs \[[@b1-medscimonit-25-341]\]. Patients with WMLs often show increased risk of cognitive decline, especially in the attention, executive function, and information processing speed domains \[[@b2-medscimonit-25-341],[@b3-medscimonit-25-341]\], and these patients consume a large amount of health resources. The onset of WMLs is insidiously destructive, and the corresponding cognitive decline is generally unnoticeable in the early stage of disease \[[@b2-medscimonit-25-341]\]; while at the same time the high prevalence of WMLs has always been considered inevitable in the elderly population \[[@b4-medscimonit-25-341]\]. Therefore, in recent years, it has become critical to determine how WMLs affect the cognitive function at an early disease stage by applying novel techniques such as function MRIs (fMRIs) or electroencephalography (EEG) in humans or animal's studies, and in most studies consistent results have been obtained \[[@b5-medscimonit-25-341]--[@b9-medscimonit-25-341]\]. Previous studies primarily focused on interpreting the alterations in contrast, spatial, and temporal resolution of images when applying tasked-based fMRI to decode related maps implicated in their associations. However, sometimes task completion is simply not possible, particularly for dementia patients. Recent studies have suggested that, regardless of the method of evaluation, specific cognitive functions arguably rely on distinct brain networks, such as the default mode network (DMN) and the fronto-parietal network \[[@b10-medscimonit-25-341],[@b11-medscimonit-25-341]\]. Unlike task-based imaging that highlights a single brain network associated with any given task, resting state fMRI (rs-fMRI) can be simultaneously applied to multiple networks, and thus help the researchers assess the alterations in brain functional connectivity of dementia patients who simply cannot complete certain challenging tasks \[[@b12-medscimonit-25-341]\]. Therefore, rs-fMRI has been regarded as one of the most promising techniques for neuroscientists to decode brain activity, especially for elderly or patients with dementia.

The human brain has been widely considered to execute function through integrated networks, and the disruption of these networks has been reported in patients with cognitive impairment \[[@b13-medscimonit-25-341]--[@b15-medscimonit-25-341]\]. Both structural and functional brain networks are thought to be characterized by small-world principles regardless of either behaving or resting status \[[@b16-medscimonit-25-341],[@b17-medscimonit-25-341]\]. The small-world network is a highly efficient model and is characterized by a greater local interconnectivity with short path lengths \[[@b18-medscimonit-25-341],[@b19-medscimonit-25-341]\], enabling maximal efficiency in information processing at a minimal cost \[[@b20-medscimonit-25-341]--[@b25-medscimonit-25-341]\]. In recent years, rs-fMRI has been widely employed for the evaluation of global brain networks as well as for categorization of the disrupted small-world networks under several major conditions, including Alzheimer's disease, multiple sclerosis, traumatic brain injury, and epilepsy \[[@b26-medscimonit-25-341],[@b27-medscimonit-25-341]\]. In particular, numerous studies mainly have focused on functional abnormalities in WM integrity and structural connectivity, e.g., studies on disruptions of frontal-subcortical neuronal circuits \[[@b15-medscimonit-25-341]\]. To the best of our knowledge, few studies have investigated whether dysfunction of intrinsic functional connectivity regarding global features of brain networks also occurs in WMLs patients with cognitive impairment.

This study aimed to assess the disruption of the small-world network in patients with WMLs, as well as to evaluate the correlation between the extent of alterations in small-world network and the severity of cognitive impairment, by using graph theoretical analyses \[[@b28-medscimonit-25-341]--[@b30-medscimonit-25-341]\] to compare the small-world properties between normal control participants without memory complaints and patients with WMLs and cognitive impairment. In addition, correlations between small-world properties and corresponding cognitive test performance were also analyzed.

Material and Methods
====================

Ethics statement
----------------

This study was approved by the ethics committee of Beijing Tiantan Hospital, Capital Medical University, China. All participants provided written informed consents. In accordance with mandatory requirements for patients with cognitive impairment, written informed consents were obtained from their legitimate guardians.

Study participants
------------------

Initially, we recruited 53 patients with WMLs from Beijing Tiantan Hospital, Capital Medical University, China from January 2011 to January 2013. One of the patients was later excluded from data analysis because of head motion. In addition, 35 normal control (NC) study participants without memory complaints were recruited with age, gender, and education levels matching the patients. The diagnosis of WMLs was made unanimously by 2 radiologists who independently evaluated the fluid-attenuated inversion recovery (FLAIR) MRIs visually without the knowledge of the participants' clinical profiles. The rating scales was described as followed \[[@b31-medscimonit-25-341]\]: periventricular hyperintensity (PVH) was graded as 0=absence, 1="caps" or pencil-thin lining, 2=smooth "halo", and 3=irregular PVH extending into the deep white matter. Separate deep white matter hyperintense signals (DWMH) were rated as 0=absence, 1=punctate foci, 2=beginning confluence of foci, and 3=large confluent areas. The inclusion and exclusion criteria are shown in [Table 1](#t1-medscimonit-25-341){ref-type="table"}.

Clinical cognitive assessment
-----------------------------

All study participants were instructed to complete the Chinese version of Mini Mental State Examination (MMSE) \[[@b32-medscimonit-25-341]\], the Beijing version of Montreal Cognitive Assessment (MoCA), and the Clinical Dementia Rating scale (CDR) under the supervision of a physician. The tests were completed in a strict order in accordance with standard protocols in a quiet room. The following education-specific reference cutoff values for MMSE scores were used: middle and high-27, elementary-24 and illiterate-21 \[[@b33-medscimonit-25-341]\]. Regarding to MoCA, the cutoff value for cognitive impairment was \< 26 \[[@b34-medscimonit-25-341]\]. In addition, one additional point was added to the raw MoCA score when the participant's years of education were fewer than 12 years \[[@b33-medscimonit-25-341]\].

Based on the results of these cognitive tests, the study participants were divided into 3 groups: patients with non-dementia vascular cognitive impairment (WMLs-VCIND, n=32), patients with vascular dementia (WMLs-VaD, n=20), and the normal control (NC, n=35). The WMLs-VCIND patients complied with the following criteria: 1) Clinical Dementia Rating (CDR)=0.5; 2) 24≤ MMSE \<27 with years of education ≥6, or 20≤ MMSE \<24 with years of education years \<6, or 17≤ MMSE \<21 with years of education=0; and 3) MoCA \<26. The WMLs-VaD patients complied with the following criteria: 1) CDR ≥1; 2) MMSE \<24 with ≥6 years of education, MMSE \<20 with \<6 years of education, or MMSE \<17 with 0 years of education; and 3) MoCA \<22. The normal control group complied with the following criteria: 1) MRI showed normal brain structure; 2) CDR=0; 3) MMSE ≥27 with years of education ≥6, or MMSE ≥24 with years of education \<6, or MMSE ≥21 with years of education=0; and 4) MoCA ≥26.

Brain MRI data acquisition
--------------------------

MRI was performed on a Siemens Magnetom Verio 3T superconducting MRI system in the Department of Radiology, Beijing Tiantan Hospital. A T~2~W-FLAIR sequence was applied to detect WM hyperintensities. A standard T~1~-weighted 3D magnetization prepared rapid gradient echo sequence was applied with repetition time (TR)=2300 ms, echo time (TE)=3.28 ms, time inversion (TI)=1200 ms, matrix size=256×256, flip angle (FA)=9°, slice thickness=1 mm, interslice gap= 0.5 mm, and number of slices=256. Resting-state blood oxygenation level-dependent (BOLD) fMRI was performed in the axial plane using an echo-planar imaging (EPI) sequence with TR=2000 ms, TE=30 ms, FA=90°, field of view=256×256 mm^2^, matrix size=64×64, NEX=1, slice thickness=3.7 mm, interslice gap=0.5 mm, number of slices=32, and acquisition time=480 seconds. A total of 240 image volumes were obtained from each study participant. Participants were instructed to stay awake, relax with their eyes closed, and remain as motionless as possible during resting fMRI scan. Rubber earplugs were used to reduce noise, and foam cushions were used to fix their head to minimize potential motion artifacts.

Rest-fMRI data preprocessing
----------------------------

Rest-fMRI data were preprocessed using the advanced DPARSF module of the DPABI pipeline (a toolbox for Data Processing and Analysis of Brain Imaging; *<http://www.rfmri.org>*) \[[@b35-medscimonit-25-341]\]. Briefly, after converting the DICOM files to NIFTI images, the first 10 time points were discarded. Then, slice timing and head motion correction were performed. One participant was excluded from the data analysis due to excessive head movement (exceeded 3.0 mm translation or 3° rotations in any direction). The data were then normalized to the standard Montreal Neurological Institute (MNI) space and re-sampled to 3-mm isotropic voxels. After smoothing with a 6 mm full width at the half maximum (FWHM) Gaussian kernel, the nuisance signals were removed. The Friston 24-parameter model was utilized to regress out head motion artefacts from the realigned data. The signals from white matter and cerebrospinal fluid were also regressed out to reduce respiratory and cardiac effects. In addition, linear and quadratic trends were included as regressors because the BOLD signal exhibits low-frequency drifts. Finally, the residual time series was band-filtered within the frequency range of 0.01--0.1 Hz to remove very low frequency drift and high frequency noise.

Graph theory analysis
---------------------

On the processed EPI (echo planar imaging), the brain was segmented into 90 regions (45 for each hemisphere, see details in [Supplementary Table 1](#s1-medscimonit-25-341){ref-type="supplementary-material"}) using an anatomical marking template according to the MNI \[[@b26-medscimonit-25-341],[@b35-medscimonit-25-341]\]. Each region represented a node of the cortical network. Then, the interregional correlation coefficient matrix (*R~ij~*) of the functional connectivity network was constructed as a 90×90 undirected correlation graph for each participant by calculating Pearson's correlation coefficients between the averaged time series of each possible pair of the 90 regions. A Fisher's r-to-z transform was used to increase the normality of the correlation matrix according to the following formula: $\text{Z}_{\text{r}} = \frac{1}{2}\text{ln}\left( \frac{1 + \text{r}}{1 - \text{r}} \right)$. The r denotes the correlation coefficient between each pair, and the Z~r~ denote the transformed correlation. And subsequently, the graph was further converted into a binarized network based on network sparsity determination as follows:
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where a~ij~ refers to the Fisher r-to-z of partial correlation coefficient from node i to node j. If the edge a~ij~ exceeds a pre-defined threshold T, it is then regarded as one; otherwise it would be set to zero. To determine the threshold T, the network sparsity (Sthr) which is defined as the ratio for the number of actual edges divided by the maximum possible number of the edges in a network, was applied to each adjacent matrix. Using the network sparsity, a patient-specific T was determined to threshold each correlation matrix so that the resulting networks have the same density level (i.e., the same number of edges) across study participants and scans \[[@b36-medscimonit-25-341]\]. The network sparsity ranging between 0.05 and 0.5, with an increment of 0.05, was reconstructed for each participant in our study. Then, all topological properties were calculated using the GRETNA software (*[www.nitrc.org/projects/gretna](www.nitrc.org/projects/gretna)*), and the following small-world network attributes \[[@b22-medscimonit-25-341]\] were obtained: shortest path length (Lp), clustering coefficient (Cp), global efficiency (Eg), local efficiency (Eloc), nodal efficiency (nodalE), and small-worldness parameters \[[@b37-medscimonit-25-341]\] including lambda (λ), gamma (γ), and sigma (σ), as well as the area under curve (AUC) of λ, γ, and σ with sparsity threshold as the x axis.

Statistical analysis
--------------------

The chi-square test was used to evaluate the differences in gender distribution between the 3 groups. Kendall's W test was used to evaluate the difference in education years between the 3 groups. A one-way analysis of variance (ANOVA) was used to compare the differences in age; incidences of hypertension, diabetes mellitus, dyslipidemia; and histories of smoking and drinking. The cognitive test results, i.e., MMSE and MoCA scores, and the brain network properties including regional functional connectivity, nodalE at sparsity=0.10, and small-worldness parameters for each sparsity level in the range of 0.05--0.5 with an increment of 0.05 were all compared using analysis of covariance (ANCOVA) using age and gender as covariances. The false discovery rate (FDR) correction was performed for the multiple comparisons of functional connectivity and nodalE values. Accordingly, *P*\<0.001 was regarded as significantly different. Subsequently, Bonferroni-corrected post-hoc analysis was performed to compare the differences between the 3 groups (*P*\<0.05/N, N represented the number of comparisons). Then, the Pearson's correlation analysis with FDR correction was used to evaluate the relationship between all the significantly different brain network properties and the cognitive scores within all participants, controlling for age and gender (*P*\<0.05).

Results
=======

Demographics and cognitive impairment
-------------------------------------

As shown in [Table 2](#t2-medscimonit-25-341){ref-type="table"}, No significant differences were found in age, gender, years of education, the incidences of hypertension, diabetes mellitus, dyslipidemia; or histories of smoking and drinking between the groups. MMSE (*F*=46.415, *P*=0.000) and MoCA (*F*=71.962, *P*=0.000) were significantly different across groups with WMLs-VAD patients greater impaired compared to the other groups.

Group differences in regional functional connectivity (FC)
----------------------------------------------------------

The ANCOVA test of the total 90\*89/2=4005 regional FC pairs showed no significant differences (*P*\<0.05, FDR corrected) among the 3 groups. While a less strict criterion (*P*\<0.001) was used to find any possible changes, there were 39 regional FC pairs left ([Figure 1](#f1-medscimonit-25-341){ref-type="fig"}, [Table 3](#t3-medscimonit-25-341){ref-type="table"}), and half of them were across 2 hemispheres. Among these 39 regional FC pairs, Bonferroni-corrected post-hoc tests were performed. These identified several regional FC pairs with significant differences between each pair of the 3 groups (*P*\<0.05/39=0.00128). Then, we found that the rough change pattern of FC strength was WMLs-VAD \< WMLs-VCIND \< normal control ([Figure 1](#f1-medscimonit-25-341){ref-type="fig"}, [Table 3](#t3-medscimonit-25-341){ref-type="table"}).

Group differences in global network properties
----------------------------------------------

[Figure 2](#f2-medscimonit-25-341){ref-type="fig"} displays the global network properties in the 3 groups at each sparsity level in the range of 0.05--0.5 with an increment of 0.05. Statistically significant differences (ANCOVA test, *P*\<0.05) were found among different groups, including Lp and Eg at sparsity=0.10/0.15/0.20, λ at sparsity=0.05, σ at sparsity=0.05, and AUC of Eg and Lp ([Figure 2](#f2-medscimonit-25-341){ref-type="fig"}, [Table 4](#t4-medscimonit-25-341){ref-type="table"}). A Bonferroni-corrected post-hoc test showed that compared with the normal control group, both the WMLs-VCIND group and WMLs-VAD group had lower Eg and higher Lp. No significant difference was found between the WMLs-VAD group and the WMLs-VCIND group ([Table 4](#t4-medscimonit-25-341){ref-type="table"}).

Group differences in nodal efficiency (nodalE)
----------------------------------------------

The nodalE values of all 90 nodes at sparsity=0.10 were compared across groups. Significant differences were found in the bilateral rolandic operculum (ROL), bilateral amygdala (AMYG), and the left temporal pole (superior temporal gyrus part) (TPOsup) across groups (*P*\<0.05, FDR corrected) ([Figure 1](#f1-medscimonit-25-341){ref-type="fig"}, [Table 5](#t5-medscimonit-25-341){ref-type="table"}). WMLs-VCIND patients showed lower nodalE in bilateral AMYG. By contrast, WMLs-VAD patients showed lower nodalE in bilateral ROL, right AMYG, and left TPOsup (*P*\<0.01, Bonferroni corrected). Compared with WMLs-VCIND patients, WMLs-VAD patients showed lower nodalE in left ROL (*P*\<0.01).

Relationship between small-world network properties and cognitive scores
------------------------------------------------------------------------

FC between 5 pairs of brain regions (i.e., AMYG.L and bilateral supramarginal gyrus ROL.R and TPOsup.R, right inferior occipital gyrus and right paracentral lobule, and left parahippocampal gyrus to supramarginal gyrus) were significantly correlated with MoCA score in all participants combined ([Figure 3](#f3-medscimonit-25-341){ref-type="fig"}, [Table 6](#t6-medscimonit-25-341){ref-type="table"}). However, there were no significant correlations between FC pairs with MMSE score ([Table 6](#t6-medscimonit-25-341){ref-type="table"}). The nodalE value of TPOsup.L significantly correlated with both MMSE (r=0.296, *P*=0.006) and MoCA (r=0.318, *P*=0.003). In addition, the nodalE of ROL.R significantly correlated with MoCA (r=0.297, *P*=0.006). Eg (sparsity=0.10, r=0.251, *P*=0.021), Lp (sparsity=0.10, r=−0.250, *P*=0.021), γ (sparsity=0.05, r=0.285, *P*=0.008), and σ (sparsity=0.05, r=0.255, *P*=0.018) were significantly correlated with MoCA (*P*\<0.05) ([Figure 4](#f4-medscimonit-25-341){ref-type="fig"}, [Table 6](#t6-medscimonit-25-341){ref-type="table"}). No significant correlations were found between global metrics and MMSE ([Table 6](#t6-medscimonit-25-341){ref-type="table"}).

Discussion
==========

In the present study, we applied rs-fMRI with graph theoretical analysis to examine the small-world properties in normal control study participants, WMLs-VCIND patients, and WMLs-VAD patients. Our results revealed different patterns of functional connectivity between groups. That is, the FC strength was most impaired in the WMLs-VAD group compared to the other groups. In addition, patient groups showed disturbed small-world networks (lower Eg and higher Lp), compared to the normal control study participants. In nodalE, functional connectivity networks showed altered nodal characteristic in both cortical and subcortial regions, such as the bilateral rolandic operculum (ROL), bilateral amygdala (AMYG), and the left temporal pole (superior temporal gyrus part) (TPOsup). Finally, significant correlations were found between small-world network properties and cognition in WMLs patients.

Altered global network properties
---------------------------------

Consistent with previous studies \[[@b38-medscimonit-25-341],[@b39-medscimonit-25-341]\], our study showed that small-world network properties were conserved in WMLs patients with cognitive impairment. The human brain is viewed as a complex but efficient neural network to maximize the power of information processing for the large clustering coefficients but short characteristic path lengths \[[@b40-medscimonit-25-341],[@b41-medscimonit-25-341]\]. Such a topology has been related to normal human cognitive functioning \[[@b16-medscimonit-25-341],[@b42-medscimonit-25-341]--[@b46-medscimonit-25-341]\]. However, in this study, WMLs patients with different levels of cognitive impairment all showed longer characteristic path lengths and lower global efficiency over a wide range of sparsity than normal control study participants. This study finding provides further evidence that WMLs patients with cognitive impairment have an altered small-worldness ([Figure 2](#f2-medscimonit-25-341){ref-type="fig"}) and suggests that the neural architecture of WMLs patients with cognitive impairment might be less optimized than normal control study participants.

Functional connectivity defines the temporal correlation between functional measurements between different areas \[[@b47-medscimonit-25-341]\]. In this study, the functional connectivity strength was significantly lower in patients with WMLs than normal control study participants, which means the extent of local connectedness decreased in WMLs patients. In addition, compared with normal control study participants, WMLs patients had longer Lp. The Lp is considered a measure of the global capacity for parallel information integration between different cortical regions \[[@b40-medscimonit-25-341],[@b42-medscimonit-25-341]\]. Information interactions between interconnected brain regions are believed to be a basis of the human cognitive process \[[@b28-medscimonit-25-341],[@b48-medscimonit-25-341],[@b49-medscimonit-25-341]\]. The longer Lp in WMLs patients might suggest that information processing between distant brain regions is disrupted, providing additional evidence for mechanisms of cognitive impairment. Compared with normal control study participants, WMLs patients showed a significant decrease in global efficiency (Eg). Eg is an index for the overall capacity or efficiency of the parallel information transfer and integrated processing in the network. Our results suggest that the Eg decrease might be a marker of brain functional plasticity \[[@b50-medscimonit-25-341],[@b51-medscimonit-25-341]\].

Altered nodal network properties
--------------------------------

The nodal efficiency (nodalE) is an index for reflecting the roles of nodes in information processing \[[@b50-medscimonit-25-341],[@b52-medscimonit-25-341]\]. The present study showed that compared with normal control study participants, WMLs-VCIND patients and WMLs-VaD patients had altered nodal characteristic in the cortical and subcortical regions.

We observed the amygdala presented a nodalE decrease in WMLs-VCIND patients, although these alterations were not correlated with cognitive scores. Abnormal amygdala activity is believed to be associated with decreased social intelligence and other related symptoms, such as difficulty in memory \[[@b53-medscimonit-25-341]\]. The amygdala may be an important hub that participates in the pathological process of cognitive impairment. The decreased functional connectivity from the amygdala to other brain regions might reflect a disruption in a "relevance detection network" which affects the processing of stimuli that are relevant for the organism's self-regulating functions \[[@b54-medscimonit-25-341]\]. More behavioral and neuroimaging studies should be conducted to test this hypothesis.

Unexpectedly, we found that the altered nodes of regional functional connectivity in WMLs-VaD patients were asymmetrically distributed. The right amygdala and the left temporal pole regions showed a decrease in nodalE*.* Furthermore, these alterations were correlated with the cognitive scores. The amygdala is considered a part of the default mode network \[[@b55-medscimonit-25-341],[@b56-medscimonit-25-341]\]. The abnormal default mode network function might underlie the pathophysiological mechanism of cognitive impairment \[[@b50-medscimonit-25-341],[@b51-medscimonit-25-341],[@b57-medscimonit-25-341]\]. The present results reconfirm the amygdala as one of the hub nodes in the brain's default network. The WMLs-VaD patients had lower nodalE in the bilateral ROL, which are implicated in the semantic processing of language \[[@b58-medscimonit-25-341],[@b59-medscimonit-25-341]\]. Of note, the alterations were correlated with the MoCA score. These results may suggest that the ROL is a hub brain node for processing cognition.

Relationship between topological measurements and cognitive behaviors
---------------------------------------------------------------------

Importantly, the clinical cognitive scores were correlated with small-world network topological properties (FC, nodalE, Eg, Lp, λ, σ). A severe cognitive impairment has been widely regarded as being correlated with a number of factors, including lower degree of connectivity, lower global and local efficiency, and a longer absolute path length and decreased small-worldness \[[@b22-medscimonit-25-341]\]. These findings indicate that the altered small-world properties can serve as sensitive imaging markers for cognitive impairment in WMLs patients.

Decreased small-worldness in aged participants is thought to be caused by a reduction in the sensitivity of the neurons undergoing the stimuli \[[@b42-medscimonit-25-341]\]. In addition, WMLs can negatively affect the optimal balance between information transmission and functional integration \[[@b60-medscimonit-25-341]\]. Therefore, decreased small-worldness in WMLs patients in this study might suggest an interruption of local specialization due to white matter damage. This is compatible with the theory that small-world topology appears when networks are evolved for an optimal balance between local specialization and global integration \[[@b61-medscimonit-25-341]\]. Because the small-world network model reflects an optimal balance between local specialization and global integration, our findings and the aforementioned literature together indicate constructive reorganization, though less optimal, of brain networks secondary to WMLs \[[@b62-medscimonit-25-341]\]. Because cortical information integration is the fundamental basis of human cognitive processes \[[@b40-medscimonit-25-341]\], our results provide new insights into the association between alternations in human brain small-world properties and cognitive dysfunction associated with WMLs.

The MoCA score is an established biomarker for cognitive impairment. The results of this study showed that the small-world properties correlated with the MoCA score but not the MMSE score. This finding was consistent with a previous finding that the MMSE score is insensitive to mild cognitive impairment \[[@b63-medscimonit-25-341]\].

Limitations
-----------

Despite these promising findings, there were limitations to our study. In additional to functional brain networks, future research is warranted to clarify structural brain networks with diffusion tensor imaging to establish an integrated view of structural and functional brain network changes and their associations with cognition in WMLs. Despite the fact that we cannot make direct connections between different levels of cognitive impairment and global features of the brain network, possibly due to the small sample properties, future studies exploring the differences pertaining to the distinctive features of the small-world network with a larger cohort of patients, WMLs-VCIND and WMLs-VAD patients in particular, based on their clinical stratification or even different scaling of cognitive dysfunction, should be further carried out.

Conclusions
===========

The present study comprehensively compared the small-world topological properties in WMLs patients with cognitive impairment with those in normal control study participants. Our results are in line with the concept that the brain is an economical small-world functional network. Specifically, we found that WMLs patients had altered small-world properties as characterized by low local and global efficiency at a relatively low wiring cost, suggesting constructive reconstruction following white matter damage. The lower global and nodal efficiency of WMLs patients suggest a loss of economic organization of the brain's functional network. Importantly, the network efficiency is significantly negatively correlated with the level of cognitive impairment, which leads us to believe that the changes in the small-world network topological characteristics might provide new insights into the pathophysiology of cognitive impairment in WMLs. The graph theoretical analysis of small-world properties can potentially be used to evaluate the progression of cognitive impairment in WMLs patients.

Supplementary Table
===================

###### 

Cortical and sub-cortical regions defined in automated anatomical labeling template image.

  ---- ---------------------- ---- ------------------- ---- ----------------------
  1    Precentral_L           31   Cingulum_Ant_L      61   Parietal_Inf_L
  2    Precentral_R           32   Cingulum_Ant_R      62   Parietal_Inf_L
  3    Frontal_Sup_L          33   Cingulum_Mid_L      63   SupraMarginal_L
  4    Frontal_Sup_R          34   Cingulum_Mid_R      64   SupraMarginal_R
  5    Frontal_Sup_Orb_L      35   Cingulum_Post_L     65   Angular_L
  6    Frontal_Sup_Orb_R      36   Cingulum_Post_R     66   Angular_R
  7    Frontal_Mid_L          37   Hippocampus_L       67   Precuneus_L
  8    Frontal_Mid_R          38   Hippocampus_R       68   Precuneus_R
  9    Frontal_Mid\_ Orb_L    39   ParaHippocampal_L   69   Paracentral_Lobule_L
  10   Frontal_Mid\_ Orb_R    40   ParaHippocampal_R   70   Paracentral_Lobule_R
  11   Frontal_Inf_Oper_L     41   Amygdala_L          71   Caudate_L
  12   Frontal_Inf_Oper_R     42   Amygdala_R          72   Caudate_R
  13   Frontal_Inf_Tri_L      43   Calcarine_L         73   Putamen_L
  14   Frontal_Inf_Tri_R      44   Calcarine_R         74   Putamen_R
  15   Frontal_Inf\_ Orb_L    45   Cuneus_L            75   Pallidum_L
  16   Frontal_Inf\_ Orb_R    46   Cuneus_R            76   Pallidum_R
  17   Rolandic_Oper_L        47   Lingual_L           77   Thalamus_L
  18   Rolandic_Oper_R        48   Lingual_R           78   Thalamus_R
  19   Supp_Motor_Area_L      49   Occipital_Sup_L     79   Heschl_L
  20   Supp_Motor_Area_R      50   Occipital_Sup_R     80   Heschl_R
  21   Olfactory_L            51   Occipital_Mid_L     81   Temporal_Sup_L
  22   Olfactory_R            52   Occipital_Mid_R     82   Temporal_Sup_R
  23   Frontal_Sup_Medial_L   53   Occipital_Inf_L     83   Temporal_Pole_Sup_L
  24   Frontal_Sup_Medial_R   54   Occipital_Inf_R     84   Temporal_Pole_Sup_R
  25   Frontal_Mid\_ Orb_L    55   Fusiform_L          85   Temporal_Mid_L
  26   Frontal_Mid\_ Orb_R    56   Fusiform_R          86   Temporal_Mid_R
  27   Rectus_L               57   Postcentral_L       87   Temporal_Pole_Mid_L
  28   Rectus_R               58   Postcentral_R       88   Temporal_Pole_Mid_R
  29   Insula_L               59   Parietal_Sup_L      89   Temporal_Inf_L
  30   Insula_R               60   Parietal_Sup_R      90   Temporal_Inf_R
  ---- ---------------------- ---- ------------------- ---- ----------------------
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ANOVA

:   analysis of variance

ANCOVA

:   analysis of covariance

BOLD

:   blood oxygenation level dependent

CDR

:   Clinical Dementia Rating scale

FDR

:   false discovery rate

FLAIR

:   fluid attenuated inversion recovery

fMRI

:   functional magnetic resonance imaging

NC

:   normal control

MoCA

:   Montreal Cognitive Assessment

MMSE

:   Mini Mental State Examination

VCIND

:   non-dementia vascular cognitive impairment

WMLs

:   white matter lesions

VaD

:   vascular dementia

![Group differences in regional functional connectivity (FC) and nodal efficiency (nodalE) at sparsity=0.10. Red nodes illustrated the regions with significant ANCOVA (5 nodes; *P*\<0.05, FDR corrected) or Bonferroni-corrected post-hoc test results (*P*\<0.05/5=0.01; also see bar graphs in the bottom panel marked with \*). Lines in the figure (the top 3 panels) illustrated the FC between the connected regions were statistically different groups (yellow lines, ANCOVA test, *P*\<0.001; blue lines, Bonferroni-corrected post-hoc test, *P*\<0.05/39=0.00128). FDR -- false discovery rate; WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VAD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; nodalE -- nodal efficiency; ROL.L -- left rolandic operculum; ROL.R -- right rolandic operculum; AMYG.L -- left amygdala; AMYG.R -- right amygdala; TPOsup.L -- left superior temporal gyrus part.](medscimonit-25-341-g001){#f1-medscimonit-25-341}

![The global network properties in 3 groups at each sparsity level in the range of 0.05--0.5 with an increment of 0.05 and their AUC. \* Marked the metrics with significant differences among groups (ANCOVA test, *P*\<0.05). AUC -- area under the curve.](medscimonit-25-341-g002){#f2-medscimonit-25-341}

![Significant correlations between brain network properties (regional functional connectivity and nodal efficiency (nodalE)) and cognitive performance (MMSE and MoCA scores). WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VAD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; nodalE -- nodal efficiency; ROL.L -- left rolandic operculum; ROL.R -- right rolandic operculum; TPOsup.L -- left superior temporal gyrus part; MMSE -- Mini Mental State Examination; MoCA -- Montreal Cognitive Assessment.](medscimonit-25-341-g003){#f3-medscimonit-25-341}

![Significant correlations between brain network properties (global metrics) and cognitive performance (MoCA scores). WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VAD: WMLs patients with vascular dementia; NC -- normal controls with normal cognition; shortest path length (Lp), global efficiency (Eg), gamma (γ) and sigma (σ); MoCA -- Montreal Cognitive Assessment.](medscimonit-25-341-g004){#f4-medscimonit-25-341}

###### 

Inclusion and exclusion criteria.

  Inclusion criteria                                 Exclusion criteria
  -------------------------------------------------- ---------------------------------------------------------------------
  85≥ age ≥50                                        Cardiac or renal failure, cancer, or other severe systemic diseases
  White matter hyperintensities on FLAIR MR images   Unrelated neurological diseases
  The scale of Fazekas ≥1                            Chronic cerebral infarction or other lesions
  Presence of a contactable informant                Leukoencephalopathy of non-vascular origin
  Written informed consent                           Dementia of non-vascular origin
                                                     Psychiatric diseases or drug addiction
                                                     Consciousness disruption or aphasia
                                                     Inability or refusal to undergo brain MRI

###### 

The demographic and clinical scores of patients in the different groups.

  Variable             NC (n=35)     WMLs-VCIND (n=32)   WMLs-VaD (n=20)   F/T       *P*-value
  -------------------- ------------- ------------------- ----------------- --------- -----------
  Age, years           66.20±7.18    65.59±7.59          62.83±6.97        1.828     0.167
  Woman, n (%)         17 (47.83%)   14 (45.45%)         6 (30.43%)        1.682     0.431
  Education, n (%)                                                                   
   Primary             0             1 (4.54%)           3 (13.04%)        1.682     0.431
   Secondary           18 (52.17%)   20 (63.64%)         14 (69.56%)                 
   Superior            17 (47.83%)   11 (31.82%)         3 (17.40%)                  
  Hypertension, n(%)   13 (39.13%)   9 (27.27%)          12 (60.87%)       5.265     0.068
  Smoking, n(%)        6 (17.14%)    5 (15.62%)          4 (20%)           0.514     0.773
  Diabetes, n(%)       4 (11.45%)    2 (6.25%)           5 (25%)           1.364     0.505
  Cholesterol, n(%)    5 (14.29%)    3 (9.37%)           6 (30%)           1.094     0.579
  Body mass index      23.87±1.18    24.27±1.12          24.13±1.01        0.772     0.466
  MMSE                 28.91±1.31    25.54±1.84          22.04±1.99        89.89     0.000
  MoCA                 27.65±1.49    22.23±1.45          17.39±2.92        140.407   0.000

WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VaD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; MMSE -- Mini Mental State Examination; MoCA -- Montreal Cognitive Assessment.

###### 

Significant group differences in FC (*P*\<0.001).

  ROI 1   ROI 2   zFC (mean±std)   ANCOVA      WMLs-VCIND-NC   WMLs-VAD-NC   WMLs-VAD-WMLs-VCIND                                           
  ------- ------- ---------------- ----------- --------------- ------------- --------------------- ------- ------ ------- ------ --------- --------
  17      56      0.22±0.22        0.50±0.28   0.54±0.22       11.25         0.00                  −0.58   0.56   −5.08   0.00   −3.75     0.00
  38      89      0.39±0.13        0.46±0.17   0.58±0.18       9.80          0.00                  −2.63   0.01   −4.03   0.00   −1.59     0.11
  37      65      0.11±0.16        0.20±0.22   0.34±0.19       9.48          0.00                  −2.70   0.01   −4.39   0.00   −1.48     0.14
  54      70      0.43±0.26        0.47±0.22   0.69±0.25       9.35          0.00                  −3.72   0.00   −3.58   0.00   −0.57     0.56
  14      41      0.15±0.23        0.21±0.22   0.41±0.25       9.27          0.00                  −3.31   0.00   −3.69   0.00   −0.92     0.36
  39      63      0.00±0.24        0.16±0.19   0.29±0.27       9.25          0.00                  −2.12   0.04   −3.80   0.00   −2.54     0.01
  42      64      0.06±0.23        0.29±0.23   0.34±0.29       9.12          0.00                  −0.73   0.46   −3.59   0.00   −3.42     0.00
  16      38      0.33±0.14        0.35±0.26   0.54±0.21       8.96          0.00                  −3.18   0.00   −3.83   0.00   −0.33     0.73
  31      51      0.23±0.25        0.35±0.28   0.56±0.26       8.92          0.00                  −3.12   0.00   −4.57   0.00   −1.55     0.12
  61      75      0.37±0.22        0.36±0.24   0.54±0.19       8.79          0.00                  −3.42   0.00   −2.90   0.00   0.23      0.81
  12      41      0.12±0.24        0.18±0.27   0.39±0.27       8.77          0.00                  −3.20   0.00   −3.75   0.00   −0.86     0.39
  37      61      0.11±0.16        0.16±0.24   0.29±0.22       8.76          0.00                  −2.25   0.03   −3.20   0.00   −0.84     0.40
  41      63      0.12±0.26        0.25±0.22   0.38±0.25       8.74          0.00                  −2.17   0.03   −3.56   0.00   −1.90     0.06
  17      41      0.18±0.25        0.42±0.24   0.51±0.29       8.58          0.00                  −1.28   0.20   −4.09   0.00   −3.34     0.00
  18      84      0.47±0.28        0.74±0.26   0.78±0.31       8.53          0.00                  −0.61   0.54   −3.69   0.00   −3.46     0.00
  16      37      0.31±0.23        0.27±0.27   0.50±0.23       8.36          0.00                  −3.70   0.00   −2.88   0.00   0.54      0.58
  41      64      0.11±0.23        0.16±0.24   0.34±0.24       8.31          0.00                  −3.12   0.00   −3.47   0.00   −0.72     0.47
  16      41      0.33±0.21        0.29±0.23   0.51±0.26       8.27          0.00                  −3.57   0.00   −2.60   0.01   0.57      0.56
  12      37      0.13±0.20        0.14±0.27   0.34±0.21       8.25          0.00                  −3.35   0.00   −3.62   0.00   −0.19     0.84
  37      63      0.11±0.19        0.20±0.21   0.31±0.23       8.09          0.00                  −2.03   0.04   −3.10   0.00   −1.41     0.16
  37      62      0.07±0.15        0.05±0.27   0.23±0.18       7.99          0.00                  −3.24   0.00   −3.38   0.00   0.28      0.77
  38      55      0.49±0.18        0.59±0.23   0.72±0.24       7.98          0.00                  −2.26   0.02   −3.58   0.00   −1.48     0.14
  10      71      0.31±0.17        0.14±0.22   0.32±0.19       7.98          0.00                  −3.44   0.00   −0.31   0.75   2.74      0.00
  41      79      0.20±0.2         0.40±0.23   0.48±0.27       7.96          0.00                  −1.27   0.20   −4.07   0.00   −3.22     0.00
  80      84      0.42±0.26        0.67±0.29   0.77±0.34       7.87          0.00                  −1.27   0.20   −3.87   0.00   −3.07     0.00
  41      42      0.64±0.37        0.73±0.34   1.02±0.42       7.87          0.00                  −3.07   0.00   −3.33   0.00   −0.89     0.37
  51      58      0.39±0.28        0.51±0.31   0.70±0.23       7.84          0.00                  −2.83   0.00   −4.40   0.00   −1.42     0.15
  11      37      0.11±0.19        0.21±0.19   0.32±0.24       7.81          0.00                  −1.97   0.05   −3.16   0.00   −1.72     0.09
  41      74      0.42±0.32        0.48±0.26   0.72±0.33       7.76          0.00                  −3.27   0.00   −3.22   0.00   −0.67     0.50
  12      39      0.08±0.22        0.10±0.24   0.30±0.24       7.72          0.00                  −3.23   0.00   −3.31   0.00   −0.38     0.70
  17      81      0.96±0.26        1.19±0.26   1.23±0.28       7.66          0.00                  −0.70   0.48   −3.53   0.00   −2.99     0.00
  39      62      0.02±0.19        0.07±0.25   0.23±0.20       7.65          0.00                  −2.81   0.00   −3.75   0.00   −0.83     0.40
  31      41      0.21±0.20        0.29±0.26   0.48±0.28       7.64          0.00                  −2.72   0.00   −3.75   0.00   −1.24     0.22
  42      63      0.08±0.25        0.30±0.27   0.33±0.28       7.62          0.00                  −0.41   0.68   −3.27   0.00   −2.9572   0.0047
  11      75      0.40±0.24        0.42±0.19   0.59±0.22       7.58          0.00                  −3.27   0.00   −2.89   0.00   −0.29     0.76
  16      42      0.28±0.19        0.39±0.23   0.51±0.29       7.56          0.00                  −1.83   0.07   −3.19   0.00   −1.82     0.07
  41      88      0.46±0.18        0.34±0.29   0.59±0.26       7.55          0.00                  −3.55   0.00   −1.95   0.05   1.51      0.13
  65      72      0.13±0.25        0.22±0.17   0.37±0.19       7.53          0.00                  −3.27   0.00   −3.82   0.00   −1.43     0.15
  14      38      0.20±0.18        0.23±0.21   0.37±0.21       7.53          0.00                  −2.81   0.00   −3.10   0.00   −0.51     0.60

WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VaD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; FC -- functional connectivity; ROI -- region of interest.

###### 

Significant group differences in global network properties (*P*\<0.05).

         Sparsity         NodalE (mean ±std)   ANCOVA           WMLs-VCIND-NC    WMLs-VaD-NC   WMLs-VaD-WMLs-VCIND                                                     
  ------ ---------------- -------------------- ---------------- ---------------- ------------- --------------------- --------- --------- --------- --------- --------- --------
  Eg     0.10             0.3417± 0.0394       0.342± 0.04      0.3715± 0.0513   4.8753        0.0100                −2.6069   0.0113    −2.2371   0.0295    −0.0208   0.9835
  0.15   0.3999± 0.0394   0.4007± 0.0466       0.433± 0.0621    4.2489           0.0175        −2.3901               0.0197    −2.1440   0.0366    −0.0626   0.9504    
  0.20   0.4316± 0.0448   0.4359± 0.0627       0.4676± 0.0696   3.2255           0.0448        −1.9503               0.0555    −2.0750   0.0429    −0.2677   0.7901    
  AUC    0.1928± 0.0215   0.1961± 0.0306       0.2112± 0.0359   3.1233           0.0493        −1.8430               0.0699    −2.0788   0.0425    −0.4157   0.6794    
  Lp     0.10             2.9634± 0.3439       2.9623± 0.34     2.7396± 0.3594   4.5685        0.0131                2.5992    0.0116    2.2560    0.0282    0.0115    0.9909
  0.15   2.5218± 0.2323   2.5267± 0.2807       2.3518± 0.3084   4.0443           0.0211        2.4194                0.0184    2.1395    0.0370    −0.0648   0.9486    
  0.20   2.34± 0.2356     2.3342± 0.2941       2.1814± 0.298    3.2915           0.0422        2.1103                0.0387    2.0419    0.0461    0.0747    0.9407    
  AUC    1.1133± 0.1145   1.1088± 0.1494       1.0346± 0.154    3.1208           0.0494        1.9989                0.0498    1.9898    0.0518    0.1147    0.9091    
  γ      0.05             4.93± 1.4788         4.9776± 1.3555   6.0564± 2.0495   4.0224        0.0216                −2.5157   0.0144    −2.1545   0.0358    −0.1191   0.9057
  σ      0.05             2.7178± 0.8709       2.7719± 1.0742   3.3076± 1.372    4.1130        0.0199                −1.7677   0.0818    −1.7298   0.0895    −0.1894   0.8505

WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VaD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; Eg -- global efficiency; Lp -- shortest path length; γ -- gamma; σ -- sigma; ANCOVA -- analysis of covariance.

###### 

Significant group differences in nodal efficiency (NodalE; *P*\<0.05, FDR corrected).

  No.   Region     NodalE (mean ±std)   ANCOVA           WMLs-VCIND-NC    WMLs-VaD-NC   WMLs-VaD-WMLs-VCIND                                                   
  ----- ---------- -------------------- ---------------- ---------------- ------------- --------------------- --------- -------- --------- -------- --------- --------
  17    ROL.L      0.4056± 0.0981       0.3888± 0.0915   0.2952± 0.1187   8.2297        0.0006                −0.7222   0.4727   −3.7176   0.0005   −3.1990   0.0024
  18    ROL.R      0.4253± 0.1046       0.3765± 0.1138   0.3178± 0.078    7.0066        0.0016                −1.8274   0.0722   −3.9960   0.0002   −2.0248   0.0482
  41    AMYG.L     0.3112± 0.1458       0.1906± 0.1706   0.2122± 0.1333   6.4868        0.0024                −3.1193   0.0027   −2.4980   0.0156   0.4813    0.6324
  42    AMYG.R     0.3136± 0.1438       0.1937± 0.1724   0.2011± 0.1454   7.1397        0.0014                −3.0998   0.0029   −2.7789   0.0075   0.1589    0.8744
  83    TPOsup.L   0.3997± 0.1197       0.3582± 0.1286   0.2747± 0.1516   6.4221        0.0026                −1.3653   0.1769   −3.3768   0.0014   −2.1278   0.0383

WMLs -- white matter lesions; WMLs-VCIND -- WMLs patients with non-dementia vascular cognitive impairment; WMLs-VaD -- WMLs patients with vascular dementia; NC -- normal controls with normal cognition; nodalE -- nodal efficiency; ROL.L -- left rolandic operculum; ROL.R -- right rolandic operculum; AMYG.L -- left amygdala; AMYG.R -- right amygdala; TPOsup.L -- left superior temporal gyrus part; ANCOVA -- analysis of covariance.

###### 

Relationship between brain network properties and behaviors.

                                             MMSE    MoCA           
  ------------------------------------------ ------- ------ ------- ------
  **Global metrics (*P*\<0.05)**                                    
  Eg_0.10                                    .117    .287   .251    .021
  Eg_0.15                                    .108    .325   .192    .078
  Eg_0.20                                    .064    .562   .156    .153
  Eg_AUC                                     .066    .547   .166    .130
  Lp_0.10                                    −.095   .386   −.250   .021
  Lp_0.15                                    −.094   .392   −.190   .082
  Lp_0.20                                    −.061   .579   −.155   .157
  Lp_AUC                                     −.064   .563   −.172   .116
  Gamma_0.05                                 .208    .056   .285    .008
  Sigma_0.05                                 .207    .057   .255    .018
  **NodalE (Bonferroni *P*\<0.05/5=0.01)**                          
  ROL.L                                      .187    .087   .270    .012
  ROL.R                                      .177    .105   .297    .006
  AMYG.L                                     .241    .026   .270    .012
  AMYG.R                                     .180    .100   .205    .060
  TPOsup.L                                   .296    .006   .318    .003
  **FC (Bonferroni *P*\<0.05/39=0.00128)**                          
  FC_41--64                                  .273    .011   .366    .001
  FC_41--63                                  .265    .014   .363    .001
  FC_18--84                                  .295    .006   .362    .001
  FC_54--70                                  .262    .015   .360    .001
  FC_39--63                                  .293    .007   .351    .001

MMSE -- Mini Mental State Examination; MoCA -- Montreal Cognitive Assessment; Eg -- global efficiency; AUC -- area under the curve; Lp -- shortest path length; nodalE -- nodal efficiency; ROL.L -- left rolandic operculum; ROL.R -- right rolandic operculum; AMYG.L -- left amygdala; AMYG.R -- right amygdala; TPOsup.L -- left superior temporal gyrus part; FC -- functional connectivity.
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